Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Vasopressin in amnesia.

Literature DB >> 74520

Vasopressin in amnesia.

J C Oliveros, M K Jandali, M Timsit-Berthier, R Remy, A Benghezal, A Audibert, J M Moeglen.

Abstract

Entities: Disease Gene

Mesh：

Substances：
Vasopressins

Year: 1978 PMID： 74520 DOI： 10.1016/s0140-6736(78)90387-2

Source DB: PubMed Journal: Lancet ISSN： 0140-6736 Impact factor: 79.321

Keyword Cloud
Cited

× No keyword cloud information.

10 in total

1. Desamino-D-arg8-vasopressin (DDAVP), unlike ethanol, has no effect on a boring visual vigilance task in humans.

Authors: A Sahgal; C Wright; I N Ferrier
Journal: Psychopharmacology (Berl) Date: 1986 Impact factor: 4.530

2. Vasopressin has general rate-decreasing effects on schedules maintaining either high or low response rates.

Authors: F van Haaren; R P Heinsbroek; A Louwerse; N E van de Poll
Journal: Psychopharmacology (Berl) Date: 1986 Impact factor: 4.530

3. Inhibition by Z-Pro-D-Leu of development of tolerance to and physical dependence on morphine in mice.

Authors: R Walter; R F Ritzmann; H N Bhargava; T C Rainbow; L B Flexner; W A Krivoy
Journal: Proc Natl Acad Sci U S A Date: 1978-09 Impact factor: 11.205

4. CSF and plasma vasopressin concentrations in dementia.

Authors: P S Sørensen; M Hammer; S Vorstrup; F Gjerris
Journal: J Neurol Neurosurg Psychiatry Date: 1983-10 Impact factor: 10.154

5. Effect on memory processes of anti-vasopressin serum microinjected into the dorsal raphe nucleus: the role of catecholaminergic neurotransmission.

Authors: G L Kovács; L Vécsei; L Medve; G Telegdy
Journal: Exp Brain Res Date: 1980-02 Impact factor: 1.972

Vasopressin in amnesia.

1. Desamino-D-arg8-vasopressin (DDAVP), unlike ethanol, has no effect on a boring visual vigilance task in humans.

2. Vasopressin has general rate-decreasing effects on schedules maintaining either high or low response rates.

3. Inhibition by Z-Pro-D-Leu of development of tolerance to and physical dependence on morphine in mice.

4. CSF and plasma vasopressin concentrations in dementia.

5. Effect on memory processes of anti-vasopressin serum microinjected into the dorsal raphe nucleus: the role of catecholaminergic neurotransmission.

6. Desmopressin in nocturnal enuresis.

Review 7. Alzheimer's disease and senile dementia: biochemical characteristics and aspects of treatment.

8. Vasopressin in anergic schizophrenia. A cross-over study with lysine-8-vasopressin and placebo.

9. Hypothalamic neuropeptides and memory.

10. Effect of desmopressin on normal and impaired memory.